Literature DB >> 33918426

Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient.

Domenico Nuzzo1,2, Gaetano Cambula3, Ignazio Bacile3, Manfredi Rizzo4, Massimo Galia5, Paola Mangiapane6, Pasquale Picone1,2, Daniela Giacomazza7, Luca Scalisi8,9.   

Abstract

In the recent pandemic disease, called COVID-19, the role of neurologists and neurobiologists represents a chance to study key features of brain infection and deepen neurological manifestations of COVID-19 and other coronavirus infections. In fact, many studies suggest brain damage during infection and persistent neurological symptoms after COVID-19 infection. Reverse transcription PCR test, antibody tests, Computed Tomography (CT) of the lung, and Magnetic Resonance (MR) of the brain of the patient were periodically performed during this case report for eight months after infection. The aim of this article is to describe the prolonged neurological clinical consequences related to COVID-19. We believe it is clinically clear that we can define a post-acute COVID-19 neurological syndrome. Therefore, in patients after a severe clinical condition of COVID-19, a deepening of persistent neurological signs is necessary.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; brain damage; neurological disorders; post-COVID-19

Year:  2021        PMID: 33918426     DOI: 10.3390/brainsci11040454

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  10 in total

Review 1.  Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery.

Authors:  Yu Wu; Miora Rakotoarisoa; Borislav Angelov; Yuru Deng; Angelina Angelova
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

2.  Respiratory function assessment at the time of a new respiratory virus pandemic.

Authors:  Antonella LoMauro; Fabrizio Gervasoni; Arnaldo Andreoli; Andrea Aliverti
Journal:  Respir Med       Date:  2021-08-10       Impact factor: 4.582

3.  Ischemic Vasculitis as a Cause of Brain Disorder's in Patients with Long Covid: Case Report.

Authors:  Nizama Salihefendic; Muharem Zildzic; Haris Huseinagic
Journal:  Med Arch       Date:  2021-12

4.  Is Long COVID a State of Systemic Pericyte Disarray?

Authors:  Olcay Y Jones; Sencer Yeralan
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

5.  Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review.

Authors:  Yan Huang; Qiong Ling; Anne Manyande; Duozhi Wu; Boqi Xiang
Journal:  Front Neurosci       Date:  2022-04-22       Impact factor: 5.152

Review 6.  Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19.

Authors:  Pasquale Picone; Tiziana Sanfilippo; Rossella Guggino; Luca Scalisi; Roberto Monastero; Roberta Baschi; Valeria Mandalà; Livio San Biagio; Manfredi Rizzo; Daniela Giacomazza; Clelia Dispenza; Domenico Nuzzo
Journal:  Cell Mol Neurobiol       Date:  2022-09-14       Impact factor: 4.231

Review 7.  Post-COVID Syndrome: An Insight on Its Pathogenesis.

Authors:  Helena C Maltezou; Androula Pavli; Athanasios Tsakris
Journal:  Vaccines (Basel)       Date:  2021-05-12

Review 8.  Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.

Authors:  Domenico Nuzzo; Sonya Vasto; Luca Scalisi; Salvatore Cottone; Gaetano Cambula; Manfredi Rizzo; Daniela Giacomazza; Pasquale Picone
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

9.  The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type.

Authors:  Ibrahim A Kira; Hanaa A M Shuwiekh; Jeffrey S Ashby; Sayed Ahmed Elwakeel; Amthal Alhuwailah; Mariam Sous Fahmy Sous; Shadia Bint Ali Baali; Chafika Azdaou; Enas M Oliemat; Hikmet J Jamil
Journal:  Int J Ment Health Addict       Date:  2021-07-06       Impact factor: 11.555

Review 10.  Long-COVID diagnosis: From diagnostic to advanced AI-driven models.

Authors:  Riccardo Cau; Gavino Faa; Valentina Nardi; Antonella Balestrieri; Josep Puig; Jasjit S Suri; Roberto SanFilippo; Luca Saba
Journal:  Eur J Radiol       Date:  2022-01-19       Impact factor: 3.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.